US casino in £2bn swoop on Gamesys: Bosses to hit £500m jackpot dailymail.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailymail.co.uk Daily Mail and Mail on Sunday newspapers.
Published: Dec 24, 2020 By Alex Keown
The European Union (EU) authorized
ViiV Healthcare’s Vocabria (cabotegravir injection and tablets) in conjunction with Janssen’s Edurant (rilpivirine tablets) for the treatment of HIV-1 infection in adults who are virologically suppressed. Vocabria is intended for adults who are virologically suppressed on a stable antiretroviral regimen without present or past evidence of viral resistance to, and no prior virological failure with agents of the NNRTI and INI class. The approval of ViiV’s treatment is the first time HIV-1 patients in Europe may be able to receive a long-acting injectable treatment that removes the need to take daily oral tablets, following the oral initiation phase.
Investment in Poland
Top Poland Investment threads on Twitter
US signs Enhanced Defense Cooperation Agreement with Poland. Big step forward for our Transatlantic security, strengthens NATO, says SecState Pompeo. Twitter
Lockheed Martin. Nice new Lockheed Martin animation showing employment of #PrSM against an enemy FARP & SAM site that are located by #F35|s on a deep strike mission. A M142 #HIMARS launches 2 PrSMs, one against the FARP, one against the S-400’s 92N6 fire-control radar. (
GeneMe, a Gdańsk, Polish-based biotechnology company pioneering a universal molecular genetic tests platform, completed a €5.2M round of seed funding.
The round was led by Robin Tombs, Co-Founder of Yoti and previously of Gamesys, and other angel investors.
The company intends to use the funds to advance its platform and further refine its development of molecular NAAT COVID-19 tests: FRANKD, SAVD, and ICED and to consolidate emergency triage services by acquiring a minority stake in the medical-box startup Medicalls.
Led by Dawid Nidzworski, CEO, GeneMe is a Polish biotech company, producing services related to polymorphisms analysis and broadly defined genetic tests. A spin-off from The Institute of Biotechnology and Molecular Medicine (IBMM), the company has developed and patented a universal protein (polymerase) for RT-LAMP testing, which allows the production of accurate, rapid, molecular genetic COVID tests. The fusion of this patented DNA polymerase with NeqSSB pr
Poland’s GeneMe secures €5.2M seed funding for its rapid COVID-19 test
GeneMe, Poland-based biotechnology company with a COVID-19 test, has secured a €5.2 million round of seed funding led by Robin Tombs, co-founder of Yoti and previously of Gamesys, and other angel investors.
The startup has developed and patented a universal protein (polymerase) for RT-LAMP testing, which allows the production of highly accurate, rapid, molecular genetic COVID tests. It has three molecular NAAT COVID-19 tests: FRANKD, SAVD and ICED. FRANKD is CE IVD-approved and FDA EUA-applied, and its solution is already utilized in over twenty countries. FRANKD has been identified, through official research made by the Scottish government, as the most accurate, rapid COVID-19 test on the market. The FRANKD solution has already been used by Heathrow Airport, Virgin Atlantic and TV show “Britain’s Got Talent.”